Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 14, 2014International Journal of CancerOpen Access

Oncometabolites‐driven tumorigenesis: From genetics to targeted therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAurélie MorinCentre National de la Recherche ScientifiqueÉLÉric LetouzéCentre National de la Recherche ScientifiqueAGAnne‐Paule Gimenez‐RoqueploDélégation Paris 5

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Morin et al. (2014) studied this question.

synapsesocial.com/papers/6a0cc4579b7efbd03a625454https://doi.org/10.1002/ijc.29080
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma2000 · 1,655 citations
  2. 2Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma2009 · 743 citations
  3. 3Germline SDHB Mutations and Familial Renal Cell Carcinoma2008 · 342 citations
  4. 4Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells2009 · 156 citations